Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Zebra Technologies Corp ha un obiettivo di prezzo di consenso pari a $335.46, stabilito in base alle ultime valutazioni degli analisti di 14. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, Truist Securities y Needham il agosto 6, 2025. Con un obiettivo di prezzo medio di $321.33 tra le Morgan Stanley, Truist Securities y Needham, c'è un implicito 5.45% upside per Zebra Technologies Corp da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/06/2025 | -1.56% | Morgan Stanley | $280 → $300 | Maintains | Equal-Weight | |||
08/06/2025 | 4.68% | Truist Securities | $269 → $319 | Maintains | Hold | |||
08/06/2025 | 13.21% | Needham | $325 → $345 | Maintains | Buy | |||
08/05/2025 | -1.23% | Barclays | $263 → $301 | Maintains | Equal-Weight | |||
07/14/2025 | 12.23% | Citigroup | $280 → $342 | Maintains | Neutral | |||
07/14/2025 | 20.43% | Baird | $320 → $367 | Maintains | Outperform | |||
06/04/2025 | 5.01% | Baird | $290 → $320 | Maintains | Outperform | |||
05/28/2025 | -8.12% | Morgan Stanley | $245 → $280 | Maintains | Equal-Weight | |||
04/30/2025 | -13.7% | Barclays | $326 → $263 | Maintains | Equal-Weight | |||
04/30/2025 | 34.54% | UBS | $425 → $410 | Maintains | Buy | |||
04/30/2025 | -4.84% | Baird | $286 → $290 | Maintains | Outperform | |||
04/30/2025 | 6.65% | Needham | $395 → $325 | Maintains | Buy | |||
04/14/2025 | -17.96% | Citigroup | $371 → $250 | Maintains | Neutral | |||
04/08/2025 | -23.87% | Morgan Stanley | $390 → $232 | Maintains | Equal-Weight | |||
04/08/2025 | -16.65% | Truist Securities | $379 → $254 | Maintains | Hold | |||
02/18/2025 | 39.46% | UBS | $445 → $425 | Maintains | Buy | |||
02/18/2025 | 24.7% | Baird | $432 → $380 | Maintains | Outperform | |||
02/14/2025 | 24.37% | Truist Securities | $409 → $379 | Maintains | Hold | |||
02/14/2025 | 6.98% | Barclays | $407 → $326 | Maintains | Equal-Weight | |||
02/14/2025 | 27.98% | Morgan Stanley | $427 → $390 | Maintains | Equal-Weight | |||
02/14/2025 | 29.62% | Needham | $430 → $395 | Maintains | Buy | |||
01/16/2025 | 34.21% | Truist Securities | $408 → $409 | Maintains | Hold | |||
01/14/2025 | 41.1% | Citigroup | → $430 | Initiates | → Neutral | |||
12/19/2024 | 33.88% | Truist Securities | $383 → $408 | Maintains | Hold | |||
12/17/2024 | 40.12% | Morgan Stanley | $400 → $427 | Maintains | Equal-Weight | |||
12/02/2024 | 31.26% | Morgan Stanley | $305 → $400 | Upgrade | Underweight → Equal-Weight | |||
10/31/2024 | 33.56% | Barclays | $347 → $407 | Maintains | Equal-Weight | |||
10/30/2024 | 39.46% | TD Cowen | $380 → $425 | Maintains | Buy | |||
10/30/2024 | 0.09% | Morgan Stanley | $290 → $305 | Maintains | Underweight | |||
10/30/2024 | 25.68% | Truist Securities | $379 → $383 | Reiterates | Hold → Hold | |||
10/30/2024 | 46.03% | UBS | $390 → $445 | Maintains | Buy | |||
10/30/2024 | 36.18% | Baird | $380 → $415 | Maintains | Outperform | |||
10/30/2024 | 41.1% | Needham | $394 → $430 | Maintains | Buy | |||
10/09/2024 | 24.37% | Truist Securities | $345 → $379 | Maintains | Hold | |||
08/02/2024 | 34.54% | Stephens & Co. | $380 → $410 | Maintains | Overweight | |||
07/31/2024 | 13.87% | Barclays | $314 → $347 | Maintains | Equal-Weight | |||
07/31/2024 | 24.7% | TD Cowen | $375 → $380 | Maintains | Buy | |||
07/31/2024 | 23.06% | Baird | $355 → $375 | Maintains | Outperform | |||
07/31/2024 | 13.21% | Truist Securities | $315 → $345 | Reiterates | Hold → Hold | |||
07/31/2024 | 29.29% | Needham | $370 → $394 | Maintains | Buy | |||
06/13/2024 | 0.09% | Exane BNP Paribas | $258 → $305 | Upgrade | Underperform → Neutral | |||
05/16/2024 | 21.41% | Needham | $352 → $370 | Maintains | Buy | |||
05/01/2024 | 20.76% | UBS | $340 → $368 | Maintains | Buy | |||
05/01/2024 | 24.7% | Stephens & Co. | $335 → $380 | Maintains | Overweight | |||
05/01/2024 | 3.37% | Truist Securities | $300 → $315 | Reiterates | Hold → Hold | |||
05/01/2024 | 23.06% | TD Cowen | $300 → $375 | Maintains | Buy | |||
05/01/2024 | 8.29% | Baird | $312 → $330 | Maintains | Outperform | |||
05/01/2024 | 15.51% | Needham | $320 → $352 | Maintains | Buy | |||
04/08/2024 | 10.59% | Wolfe Research | → $337 | Upgrade | Peer Perform → Outperform | |||
04/02/2024 | -4.18% | Barclays | → $292 | Initiates | → Equal-Weight | |||
03/14/2024 | -1.56% | Truist Securities | → $300 | Initiates | → Hold | |||
11/02/2023 | 11.57% | UBS | $370 → $340 | Maintains | Buy | |||
11/01/2023 | -1.56% | Stephens & Co. | $350 → $300 | Maintains | Overweight | |||
11/01/2023 | -16.32% | Needham | $285 → $255 | Maintains | Buy | |||
10/27/2023 | -31.09% | Morgan Stanley | $220 → $210 | Maintains | Underweight | |||
10/03/2023 | — | Keybanc | — | Initiates | → Sector Weight | |||
09/20/2023 | -27.81% | Morgan Stanley | $260 → $220 | Downgrade | Equal-Weight → Underweight | |||
09/05/2023 | -4.84% | TD Cowen | $270 → $290 | Maintains | Outperform | |||
08/03/2023 | -11.4% | TD Cowen | $350 → $270 | Maintains | Outperform | |||
08/02/2023 | -14.68% | Morgan Stanley | $295 → $260 | Maintains | Equal-Weight | |||
08/02/2023 | -7.13% | Baird | $322 → $283 | Maintains | Outperform | |||
08/02/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
08/02/2023 | -9.76% | Credit Suisse | $295 → $275 | Maintains | Outperform | |||
08/02/2023 | -6.48% | Needham | → $285 | Reiterates | Buy → Buy | |||
06/22/2023 | -3.2% | Credit Suisse | → $295 | Reiterates | Outperform → Outperform | |||
05/11/2023 | 14.85% | TD Cowen | $375 → $350 | Maintains | Outperform | |||
05/03/2023 | -3.2% | Morgan Stanley | $305 → $295 | Maintains | Equal-Weight | |||
05/03/2023 | -3.2% | Credit Suisse | $326 → $295 | Maintains | Outperform | |||
05/03/2023 | 5.66% | Baird | $365 → $322 | Maintains | Outperform | |||
05/03/2023 | 11.57% | Needham | $385 → $340 | Maintains | Buy | |||
04/25/2023 | 6.98% | Credit Suisse | $311 → $326 | Upgrade | Neutral → Outperform | |||
02/23/2023 | 2.05% | Credit Suisse | $313 → $311 | Maintains | Neutral | |||
02/21/2023 | 31.26% | Stephens & Co. | $350 → $400 | Maintains | Overweight | |||
02/17/2023 | 26.34% | Needham | $330 → $385 | Maintains | Buy | |||
02/09/2023 | 2.71% | Credit Suisse | $319 → $313 | Downgrade | Outperform → Neutral | |||
12/20/2022 | 3.37% | Baird | $300 → $315 | Maintains | Outperform | |||
12/13/2022 | -14.68% | Morgan Stanley | $225 → $260 | Maintains | Equal-Weight | |||
12/13/2022 | 4.68% | Credit Suisse | → $319 | Initiates | → Outperform | |||
12/01/2022 | — | Wolfe Research | — | Downgrade | Peer Perform → Underperform | |||
11/03/2022 | 46.03% | UBS | $485 → $445 | Maintains | Buy | |||
11/02/2022 | -1.56% | Baird | $330 → $300 | Maintains | Outperform | |||
11/02/2022 | 8.29% | Needham | $450 → $330 | Maintains | Buy | |||
10/14/2022 | -26.17% | Morgan Stanley | $335 → $225 | Maintains | Equal-Weight |
El último precio objetivo de Zebra Technologies (NASDAQ:ZBRA) fue comunicado por Morgan Stanley el agosto 6, 2025. La firma de analistas fijó un precio objetivo para $300.00 que espera ZBRA a fall dentro de 12 meses (un posible -1.56% downside). 34 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Zebra Technologies (NASDAQ:ZBRA) fue proporcionada por Morgan Stanley, y Zebra Technologies mantuvo su equal-weight calificación.
La última revisión al alza de Zebra Technologies Corp se produjo en diciembre 2, 2024, cuando Morgan Stanley elevó su precio objetivo a $400. Morgan Stanley anteriormente tenía an underweight para Zebra Technologies Corp.
La última revisión a la baja de Zebra Technologies Corp se produjo en septiembre 20, 2023, cuando Morgan Stanley cambió su precio objetivo de $260 a $220 para Zebra Technologies Corp.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Zebra Technologies, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Zebra Technologies se registró el agosto 6, 2025, por lo que la próxima calificación estará disponible en torno al agosto 6, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Zebra Technologies (ZBRA) fue un mantuvo con un precio objetivo de $280.00 a $300.00. El precio actual al que cotiza Zebra Technologies (ZBRA) es de $304.74, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.